{"content":"<li class=\"n-box-item date-title\" data-end=\"1466654399\" data-start=\"1466568000\" data-txt=\"Sunday, December 22, 2019\">Wednesday, June 22, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3190158\" data-ts=\"1466632204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCS\" target=\"_blank\">SCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190158-steelcaseminus-10-on-weak-outlook-order-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steelcase -10% on weak outlook, order decline</a></h4><ul>     <li>Steelcase (NYSE:<a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a>) <font color='red'>-9.9%</font>&nbsp;AH after beating <a href=\"https://seekingalpha.com/news/3190120-steelcase-beats-0_02-beats-revenue\" target=\"_blank\">FQ1 earnings</a> estimates but issuing <a href=\"http://www.marketwatch.com/story/steelcase-shares-slide-on-pessimistic-outlook-2016-06-22-17485331\" target=\"_blank\">downside guidance</a> for its current quarter, which the office furniture and workspace company blames on a decline in orders.</li><li>SCS now sees FQ2 EPS of $0.29-$0.33 vs. $0.37 analyst consensus estimate, on revenue of $770M-$795M, below the  average analyst estimate of $827M and down 3%-6% from the year-ago quarter.</li><li>SCS cites the lingering downturn in the  energy sector and a significant decrease in orders in the U.K. among the reasons for the order decline.</li><li>SCS says sales in the Americas segment rose 0.1% Y/Y to  $520.4M, while sales for the Europe, Middle East and Africa segment added 4.5% to $125.3M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190158\" data-linked=\"Steelcase -10% on weak outlook, order decline\" data-tweet=\"$SCS - Steelcase -10% on weak outlook, order decline https://seekingalpha.com/news/3190158-steelcaseminus-10-on-weak-outlook-order-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3190158-steelcaseminus-10-on-weak-outlook-order-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190153\" data-ts=\"1466631419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190153-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/APOG\" title=\"Apogee Enterprises, Inc.\">APOG</a> <font color=\"green\">+7.6%</font>. <a href=\"https://seekingalpha.com/symbol/BKS\" title=\"Barnes &amp; Noble Inc\">BKS</a> <font color=\"green\">+5.8%</font>. <a href=\"https://seekingalpha.com/symbol/ESV\" title=\"Ensco PLC\">ESV</a> <font color=\"green\">+4.9%</font>. <a href=\"https://seekingalpha.com/symbol/MLHR\" title=\"Herman Miller, Inc.\">MLHR</a> <font color=\"green\">+4.5%</font>. <a href=\"https://seekingalpha.com/symbol/VALE\" title=\"Vale S.A.\">VALE</a> <font color=\"green\">+2.5%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/SCS\" title=\"Steelcase Inc.\">SCS</a> <font color=\"red\">-9.9%</font>. <a href=\"https://seekingalpha.com/symbol/IBN\" title=\"ICICI Bank Ltd.\">IBN</a> <font color=\"red\">-8.8%</font>. <a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a> <font color=\"red\">-5.7%</font>. <a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a> <font color=\"red\">-4.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190153\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$APOG $BKS $VAL - After Hours Gainers / Losers https://seekingalpha.com/news/3190153-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3190153-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190151\" data-ts=\"1466631231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190151-bed-bath-beyondminus-5-after-missing-earnings-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond -5% after missing earnings expectations</a></h4><ul>     <li>Bed Bath &amp; Beyond (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a>) <font color=\"red\">-4.8%</font> AH after reporting weaker than expected <a href=\"https://seekingalpha.com/news/3190127-bed-bath-and-beyond-misses-0_06-misses-revenue\" target=\"_blank\">FQ1 earnings</a> on flat sales, as the company <a href=\"http://www.wsj.com/articles/bed-bath-beyond-results-miss-targets-1466629949\" target=\"_blank\">continues to struggle</a> with the shift away from brick-and-mortar stores.</li>     <li>However, BBBY affirms its FY 2017 profit outlook, seeing EPS \"comfortably\" in the range it has earned over last several years during a heavy investment phase of $4.50-$5.00 vs. $4.98 analyst consensus estimate.</li>     <li>BBBY says sales at stores open for at least a year fell 0.5% during the quarter, compared with a year-earlier increase of 2.2% and analyst expectations for a 0.6% increase; gross margin narrowed to 37.4% from 38.1% a year ago.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190151\" data-linked=\"Bed Bath &amp; Beyond -5% after missing earnings expectations\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond -5% after missing earnings expectations https://seekingalpha.com/news/3190151-bed-bath-beyondminus-5-after-missing-earnings-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3190151-bed-bath-beyondminus-5-after-missing-earnings-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190147\" data-ts=\"1466630151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOG\" target=\"_blank\">APOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190147-apogee-enterprisesplus-7-ah-following-fq1-beat-and-fy17-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apogee Enterprises +7% AH following FQ1 beat and FY17 guidance</a></h4><ul>     <li>Apogee Enterprises (NASDAQ:<a href=\"https://seekingalpha.com/symbol/APOG\" title=\"Apogee Enterprises, Inc.\">APOG</a>) says it expects FY17 revenue growth of 10% and EPS of $2.70-$2.85, versus prior guidance of $2.65-$2.80 and the consensus of $2.72.</li>\n<li>Shares <font color=\"green\">+7.75% AH.</font>\n</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3190138-apogee-beats-0_12-beats-revenue\" target=\"_blank\">Apogee beats by $0.12, beats on revenue</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190147\" data-linked=\"Apogee Enterprises +7% AH following FQ1 beat and FY17 guidance\" data-tweet=\"$APOG - Apogee Enterprises +7% AH following FQ1 beat and FY17 guidance https://seekingalpha.com/news/3190147-apogee-enterprisesplus-7-ah-following-fq1-beat-and-fy17-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3190147-apogee-enterprisesplus-7-ah-following-fq1-beat-and-fy17-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190138\" data-ts=\"1466628594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOG\" target=\"_blank\">APOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190138-apogee-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apogee beats by $0.12, beats on revenue</a></h4><ul>\n<li>Apogee (NASDAQ:<a href=\"https://seekingalpha.com/symbol/APOG\" title=\"Apogee Enterprises, Inc.\">APOG</a>): FQ1 EPS of $0.61 <font color=\"green\">beats by $0.12</font>.</li>\n<li>Revenue of $247.88M (+3.3% Y/Y) <font color=\"green\">beats by $0.7M</font>.</li>\n<li>Shares <font color=\"green\">+8%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190138\" data-linked=\"Apogee beats by $0.12, beats on revenue\" data-tweet=\"$APOG - Apogee beats by $0.12, beats on revenue https://seekingalpha.com/news/3190138-apogee-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3190138-apogee-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190137\" data-ts=\"1466628526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLHR\" target=\"_blank\">MLHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190137-herman-millerplus-4-ah-following-fq4-beat-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herman Miller +4% AH following FQ4 beat, guidance</a></h4><ul>     <li>Herman Miller (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MLHR\" title=\"Herman Miller, Inc.\">MLHR</a>) expects Q1 revenue of $600M-$620M and EPS of $0.60-$0.64 vs. a consensus of $589.3M and $0.60.</li>\n<li>The company also announced <font color=\"green\">15% increase</font> in its quarterly cash dividend to $0.17/share payable in October 2016.</li>\n<li>Shares <font color=\"green\">+4%</font> AH</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3190121-herman-miller-beats-0_04-beats-revenue\" target=\"_blank\">Herman Miller beats by $0.04, beats on revenue</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190137\" data-linked=\"Herman Miller +4% AH following FQ4 beat, guidance\" data-tweet=\"$MLHR - Herman Miller +4% AH following FQ4 beat, guidance https://seekingalpha.com/news/3190137-herman-millerplus-4-ah-following-fq4-beat-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3190137-herman-millerplus-4-ah-following-fq4-beat-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190123\" data-ts=\"1466626225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASC\" target=\"_blank\">CASC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190123-cascadian-announces-public-equity-offering-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cascadian announces public equity offering; shares down 6% after hours</a></h4><ul>\n<li>Nano cap Cascadian Therapeutics (NYSE:<a href=\"https://seekingalpha.com/symbol/CASC\" title=\"Cascadian Therapeutics, Inc\">CASC</a>) initiates a public offering of common stock. Price, volume and terms have yet to be announced. Shares are off <font color=\"red\">6%</font> after hours on light volume.</li>\n<li>\n<strong>Update</strong>: On June 23, the company announced that the offering is 35M shares at $0.80 per share. Underwriters over-allotment is an additional 5.25M shares. In addition, the company has agreed to sell 17,250 shares of its Series D Convertible Preferred Stock at $800 per share to BVF Partners, L.P., an entity consisting of existing stockholders and affiliates of a board member. Each Series D share is convertible into 1,000 shares of common stock.</li>\n<li>\n<strong>Update</strong>: On June 28, the company announced the closing of the offering, including the full exercise of the 5.25M-share over-allotment. Gross proceeds were $32.2M. The Series D offering also closed yielding gross proceeds of $13.8M. Total haul: $46.0M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190123\" data-linked=\"Cascadian announces public equity offering; shares down 6% after hours\" data-tweet=\"$CASC - Cascadian announces public equity offering; shares down 6% after hours https://seekingalpha.com/news/3190123-cascadian-announces-public-equity-offering-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3190123-cascadian-announces-public-equity-offering-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190122\" data-ts=\"1466626000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190122-chanos-on-tesla-solarcity-corporate-governance-worst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chanos on Tesla/SolarCity: Corporate governance at its worst</a></h4><ul><li>\"A shameful example of corporate governance at its worst,\" <a href=\"http://www.cnbc.com/2016/06/22/chanos-bail-out-of-solarcity-a-corporate-governance-at-its-worst.html\" target=\"_blank\">says Jim Chanos</a>, commenting on Tesla's (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-10.5%</font>) offer to buy SolarCity (SCTY <font color='green'>+3%</font>).</li><li>He notes SolarCity's bonds yield 20%, suggesting a company in financial distress. The hundreds of millions in cash it is burning through each quarter will now be a burden Tesla owners will have to bear.</li><li>Consider this, he says: The combined market drop today is greater than the equity value of the deal itself - meaning Tesla shareholders think SCTY stock is essentially worthless.</li><li>\"Finally, it is hard for me to believe that this deal was not being contemplated when Tesla, and Mr. (Elon) Musk himself, sold shares just a few weeks ago.\"</li><li>Chanos, of course, is short the stock of both companies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3190122\" data-linked=\"Chanos on Tesla/SolarCity: Corporate governance at its worst\" data-tweet=\"$TSLA - Chanos on Tesla/SolarCity: Corporate governance at its worst https://seekingalpha.com/news/3190122-chanos-on-tesla-solarcity-corporate-governance-worst?source=tweet\" data-url=\"https://seekingalpha.com/news/3190122-chanos-on-tesla-solarcity-corporate-governance-worst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>148&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190121\" data-ts=\"1466625974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLHR\" target=\"_blank\">MLHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190121-herman-miller-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herman Miller beats by $0.04, beats on revenue</a></h4><ul>\n<li>Herman Miller (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MLHR\" title=\"Herman Miller, Inc.\">MLHR</a>): FQ4 EPS of $0.56 <font color=\"green\">beats by $0.04</font>.</li>\n<li>Revenue of $582.6M (+5.8% Y/Y) <font color=\"green\">beats by $14.05M</font>.</li>\n<li>Shares <font color=\"green\">+3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190121\" data-linked=\"Herman Miller beats by $0.04, beats on revenue\" data-tweet=\"$MLHR - Herman Miller beats by $0.04, beats on revenue https://seekingalpha.com/news/3190121-herman-miller-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3190121-herman-miller-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190117\" data-ts=\"1466625453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CP\" target=\"_blank\">CP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190117-canadian-pacific-upped-to-strong-buy-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Pacific upped to Strong Buy at Raymond James</a></h4><ul>     <li>Canadian Pacific (<a href=\"https://seekingalpha.com/symbol/CP\" title=\"Canadian Pacific Railway Limited\">CP</a> <font color=\"green\">+2.5%</font>) is higher after Raymond James <a href=\"http://business.financialpost.com/investing/trading-desk/cp-rails-volume-woes-create-attractive-buying-opportunity-analysts-say\" target=\"_blank\">upgrades shares to Strong Buy</a> from Outperform with a C$200 price target, saying current prices provide an opportunistic entry point for long-term investors.</li>     <li>CP <a href=\"https://seekingalpha.com/news/3189876-railroad-stocks-lower-weak-guidance-canadian-pacific\" target=\"_blank\">warned yesterday</a> that Q2 revenue will decline 12% Y/Y and adjusted EPS will fall to ~$2.00, both well below consensus forecasts; Raymond James admits the guidance was weak but says it is \"largely rear-view looking,\" and CP will benefit from improving volumes, fading cost headwinds and stronger bulk commodity shipments in H2 of this year.</li>\n<li>Desjardins also raises its rating on CP to Buy from Hold, believing current price levels underestimate the railroad's ability to adjust its cost structure and buy back shares to protect EPS.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190117\" data-linked=\"Canadian Pacific upped to Strong Buy at Raymond James\" data-tweet=\"$CP - Canadian Pacific upped to Strong Buy at Raymond James https://seekingalpha.com/news/3190117-canadian-pacific-upped-to-strong-buy-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3190117-canadian-pacific-upped-to-strong-buy-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190113\" data-ts=\"1466624103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASPN\" target=\"_blank\">ASPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190113-aspen-aerogels-expands-strategic-partnership-basf-sharesplus-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aspen Aerogels expands strategic partnership with BASF; shares +22%</a></h4><ul>     <li>Aspen Aerogels (<a href=\"https://seekingalpha.com/symbol/ASPN\" title=\"Aspen Aerogels, Inc.\">ASPN</a> <font color=\"green\">+22.1%</font>) pops 22% on news of an expanded strategic partnership with BASF (<a href=\"https://seekingalpha.com/symbol/BASFY\" title=\"BASF SE ADR\">OTCQX:BASFY</a> <font color=\"green\">+0.9%</font>), which includes a commitment to the exclusive supply of its Spaceloft A2 product for incorporation within BASF's aerogel enhanced slentex wall system.</li>     <li>BASF agrees to make a low double-digit million investment toward the construction of ASPN's new manufacturing plant and provide technical support in targeting manufacturing productivity, product cost and profit margins.</li>     <li>BASF says the agreement, which will run through 2027, paves the way for the two companies to develop new aerogel products and technologies.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190113\" data-linked=\"Aspen Aerogels expands strategic partnership with BASF; shares +22%\" data-tweet=\"$ASPN $ASPN $BASFY - Aspen Aerogels expands strategic partnership with BASF; shares +22% https://seekingalpha.com/news/3190113-aspen-aerogels-expands-strategic-partnership-basf-sharesplus-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3190113-aspen-aerogels-expands-strategic-partnership-basf-sharesplus-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190109\" data-ts=\"1466622015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190109-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INVT' title='Inventergy Global, Inc.'>OTC:INVT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/DAIO' title='Data I/O Corporation'>DAIO</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/LUNA' title='Luna Innovations Incorporated'>LUNA</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VMEM' title='Violin Memory, Inc.'>VMEM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190109\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$INVT $UIS $DAIO - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3190109-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3190109-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190104\" data-ts=\"1466619819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190104-energy-transfer-gains-traders-bet-judge-will-rule-in-favor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Transfer gains as traders bet judge will rule in its favor</a></h4><ul>     <li>Energy Transfer Equity (ETE <font color=\"green\">+2.6%</font>) extends yesterday's gains as Wall Street <a href=\"http://www.bloomberg.com/news/articles/2016-06-22/wall-street-bets-energy-transfer-williams-deal-is-about-to-die\" target=\"_blank\">bets the judge in the merger trial will rule in its favor</a> and against Williams Cos. (<a href=\"https://seekingalpha.com/symbol/WMB\" title=\"Williams Companies Inc\">WMB</a> <font color=\"red\">-2.7%</font>), and allow it to walk away without paying a breakup fee.</li>     <li>Bloomberg reports that the spread traded by those speculating on whether the deal will fall apart reached a record high today after the judge said <a href=\"https://seekingalpha.com/news/3189970-judges-good-faith-comments-seen-boosting-energy-transfer-vs-williams\" target=\"_blank\">yesterday</a> that a key issue is whether the lawyers hired to assess the tax implications of the deal acted in \u201cgood faith\u201d when they concluded it was marred by complications.</li>     <li>\"We believe ETE won,\u201d Evercore analyst Timm Schneider says. \u201cWe do not believe there was enough evidence that would lead the judge to rule [ETE's lawyers] acted in \u2018bad faith.\u201d\u2019</li>     <li>Bloomberg's Brandon Barnes says the court could find a way to credit both sides\u2019 arguments with an opinion that gives both something instead of declaring either party an outright winner.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190104\" data-linked=\"Energy Transfer gains as traders bet judge will rule in its favor\" data-tweet=\"$ET $ET $WMB - Energy Transfer gains as traders bet judge will rule in its favor https://seekingalpha.com/news/3190104-energy-transfer-gains-traders-bet-judge-will-rule-in-favor?source=tweet\" data-url=\"https://seekingalpha.com/news/3190104-energy-transfer-gains-traders-bet-judge-will-rule-in-favor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190101\" data-ts=\"1466618497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190101-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+14%</font>. SGY <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/YZC' title='Yanzhou Coal Mining Co. Ltd.'>YZC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/REN' title='Resolute Energy Corporation'>REN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3190101\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$RKDA $TALO $YZC - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3190101-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3190101-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190079\" data-ts=\"1466616085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATU\" target=\"_blank\">ATU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190079-actuants-fq4-and-fy16-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Actuant&#39;s FQ4 and FY16 guidance</a></h4><ul>     <li>Actuant (NYSE:<a href=\"https://seekingalpha.com/symbol/ATU\" title=\"Actuant Corporation\">ATU</a>) expects FQ4 sales of $270-280M and EPS of $0.28 -0.33 vs. consensus of $282.9M and EPS of $0.36.</li>     <li>The company now estimates full year revenue of $1.15B and EPS of $1.2-1.25 vs. consensus of $1.14B and $1.25.</li>     <li>Shares <font color=\"red\">-5%</font>.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3190008-actuant-beats-0_03-beats-revenue\" target=\"_blank\">Actuant beats by $0.03, beats on revenue</a> (June 22)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190079\" data-linked=\"Actuant&#39;s FQ4 and FY16 guidance\" data-tweet=\"$ATU $EPAC - Actuant&#39;s FQ4 and FY16 guidance https://seekingalpha.com/news/3190079-actuants-fq4-and-fy16-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3190079-actuants-fq4-and-fy16-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190094\" data-ts=\"1466614860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190094-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLBH' title='Carolina Bank Holdings Inc.'>CLBH</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MN' title='Manning & Napier'>MN</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FUR' title='Winthrop Realty Trust'>FUR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NYMT' title='New York Mortgage Trust, Inc.'>NYMT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BHV' title='BlackRock Virginia Municipal Bond Trust'>BHV</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3190094\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$CLBH $MN $FUR - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3190094-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3190094-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190089\" data-ts=\"1466613764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190089-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> SPU <font color='green'>+56%</font>. <a href='https://seekingalpha.com/symbol/ASPN' title='Aspen Aerogels, Inc.'>ASPN</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/INVT' title='Inventergy Global, Inc.'>OTC:INVT</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/CNXR' title='Connecture'>OTC:CNXR</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CLBH' title='Carolina Bank Holdings Inc.'>CLBH</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Aéreas Inteligentes S.A.'>GOL</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/CVTI' title='Covenant Transportation Group, Inc.'>CVTI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FUR' title='Winthrop Realty Trust'>FUR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/YECO-OLD' title='Yulong Eco-Materials'>YECO-OLD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190089\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$FTFT $ASPN $INVT - Midday Gainers / Losers https://seekingalpha.com/news/3190089-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3190089-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190088\" data-ts=\"1466613578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CETX\" target=\"_blank\">CETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190088-cemtrex-soars-on-buyback-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cemtrex soars on buyback plan</a></h4><ul>\n<li>The plan will allow the repurchase of up to 1M shares over the next year, or nearly 12% of the float. It's the company's first-ever buyback program.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/CETX\" title=\"Cemtrex, Inc.\">CETX</a> <font color=\"green\">+16.6%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190088\" data-linked=\"Cemtrex soars on buyback plan\" data-tweet=\"$CETX - Cemtrex soars on buyback plan https://seekingalpha.com/news/3190088-cemtrex-soars-on-buyback-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3190088-cemtrex-soars-on-buyback-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190084\" data-ts=\"1466612442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAN\" target=\"_blank\">PRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190084-new-data-from-pranas-mid-stage-study-of-lead-product-candidate-in-huntingtons-disease-showed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New data from Prana&#39;s mid-stage study of lead product candidate in Huntington&#39;s disease showed improvements in thinking; shares up 11%</a></h4><ul>\n<li>Thinly traded nano cap Prana Biotechnology (<a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+11.3%</font>) heads north on almost a 10x surge in volume, albeit on turnover of only 335K shares, in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1131343/000114420416109216/v442724_6k.htm\" target=\"_blank\">announcement </a>of new data from its completed Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01590888?term=reach2hd&amp;rank=1\" target=\"_blank\">REACH2HD</a>, evaluating lead product candidate PBT2 in patients with Huntington's disease. The results were presented at the 20th Annual International Movement Disorder Society Congress in Berlin, Germany.</li>\n<li>The new analysis showed that 90% of the study participants who self-reported an improvement in their thinking were on PBT2 treatment.</li>\n<li>\n<a href=\"http://pranabio.com/research-and-development/#.VWzCXc93lhE\" target=\"_blank\">PBT2 </a>is a metal protein attenuating compound (MPAC) which is designed to interrupt interactions between metals and target proteins in the brain and thereby prevent deterioration of brain cells.</li>\n<li>No word is provided about the company's plans for Phase 3 studies.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190084\" data-linked=\"New data from Prana&#39;s mid-stage study of lead product candidate in Huntington&#39;s disease showed improvements in thinking; shares up 11%\" data-tweet=\"$PRAN $ATHE - New data from Prana&#39;s mid-stage study of lead product candidate in Huntington&#39;s disease showed improvements in thinking; shares up 11% https://seekingalpha.com/news/3190084-new-data-from-pranas-mid-stage-study-of-lead-product-candidate-in-huntingtons-disease-showed?source=tweet\" data-url=\"https://seekingalpha.com/news/3190084-new-data-from-pranas-mid-stage-study-of-lead-product-candidate-in-huntingtons-disease-showed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190083\" data-ts=\"1466611252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190083-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> SPU <font color='green'>+58%</font>. <a href='https://seekingalpha.com/symbol/KEQU' title='Kewaunee Scientific Corporation'>KEQU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/FARM' title='Farmer Brothers Company'>FARM</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CMT' title='Core Molding Technologies, Inc.'>CMT</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3190083\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FTFT $KEQU $FARM - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3190083-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3190083-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190074\" data-ts=\"1466609554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBS\" target=\"_blank\">EBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190074-feds-to-procure-up-to-56_4m-doses-of-anthrax-vaccines-only-29_4m-doses-of-emergent-bios\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Feds to procure up to 56.4M doses of anthrax vaccines, but only 29.4M doses of Emergent Bio&#39;s BioThrax; shares slump 22%</a></h4><ul>\n<li>Emergent BioSolutions (<a href=\"https://seekingalpha.com/symbol/EBS\" title=\"Emergent BioSolutions Inc.\">EBS</a> <font color=\"red\">-21.9%</font>) drops on an 8x surge in volume in response to its announcement that the U.S. Department of Health and Human Services (HHS) has issued two solicitation notices for the continued procurement of 29.4M doses of BioThrax and the advanced development and procurement of up to 27M doses of a next-generation anthrax vaccine, news that appears to disappoint investors.</li>\n<li>The company believes its next-generation candidate, NuThrax, satisfies the specifications in the HHS solicitation. The contract should be awarded in September. HHS intends to sole source BioThrax. The 29.4M doses will be procured over a period of five years. The per-year amounts are not disclosed.</li>\n<li>The FDA just completed its inspection of the company's Building 55, Emergent's site for the large-scale manufacturing of BioThrax and NuThrax. No Form 483 observations were cited and no follow-up actions are needed. The agency's action date to approve the facility is August 15.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190074\" data-linked=\"Feds to procure up to 56.4M doses of anthrax vaccines, but only 29.4M doses of Emergent Bio&#39;s BioThrax; shares slump 22%\" data-tweet=\"$EBS - Feds to procure up to 56.4M doses of anthrax vaccines, but only 29.4M doses of Emergent Bio&#39;s BioThrax; shares slump 22% https://seekingalpha.com/news/3190074-feds-to-procure-up-to-56_4m-doses-of-anthrax-vaccines-only-29_4m-doses-of-emergent-bios?source=tweet\" data-url=\"https://seekingalpha.com/news/3190074-feds-to-procure-up-to-56_4m-doses-of-anthrax-vaccines-only-29_4m-doses-of-emergent-bios\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190076\" data-ts=\"1466608969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBI\" target=\"_blank\">MBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190076-monoline-bull-cuts-puerto-rico-related-loss-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monoline bull cuts Puerto Rico-related loss estimates</a></h4><ul>\n<li>While shares of MBIA (NYSE:<a href=\"https://seekingalpha.com/symbol/MBI\" title=\"MBIA Inc.\">MBI</a>) and Assured Guaranty (NYSE:<a href=\"https://seekingalpha.com/symbol/AGO\" title=\"Assured Guaranty Ltd.\">AGO</a>) were hit this week thanks to a breakdown in talks between Puerto Rico and its creditors. The breakdown shouldn't be surprising, writes Mark Palmer at BTIG, but is instead part of the normal back and forth between negotiating parties.</li>\n<li>More notable, says Palmer, is the Commonwealth's latest proposal to certain bondholders which he believes gives investors an idea of what a worst-case scenario will look like.</li>\n<li>Palmer's previous estimate of MBI's loss per share on its Puerto Rico exposure of $5.14 is cut to $4.26. For AGO, it was $6.09, but has been cut to $5.19.</li>\n<li>He reiterates his Buy ratings on both, and<a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=dhhhk-b\" target=\"_blank\"> lifts the PT on MBI</a> to $14 from $13 (100% upside). The <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=dhhik-b\" target=\"_blank\">PT on AGO remains</a> at $35 (40% upside).</li>\n<li>MBI <font color=\"green\">+3.25%</font>, AGO <font color=\"green\">+0.55%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190076\" data-linked=\"Monoline bull cuts Puerto Rico-related loss estimates\" data-tweet=\"$MBI $MBI $AGO - Monoline bull cuts Puerto Rico-related loss estimates https://seekingalpha.com/news/3190076-monoline-bull-cuts-puerto-rico-related-loss-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3190076-monoline-bull-cuts-puerto-rico-related-loss-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190072\" data-ts=\"1466608506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190072-gnc-holdings-and-vitamin-shoppe-higher-merger-chatter-still-circulating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GNC Holdings and Vitamin Shoppe higher with merger chatter still circulating</a></h4><ul> <li>Shares of GNC Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/GNC\" title=\"GNC Holdings, Inc.\">GNC</a>) are <font color=\"green\">up 2%</font> on some speculative buying that may by tied to the company's cancellation of an appearance at the Jefferies 2016 Consumer Conference (schedule for today).</li> <li>Traders are a bit jump on GNC due to the strategic review ongoing at the company. While a GNC-Vitamin Shoppe (<a href=\"https://seekingalpha.com/symbol/VSI\" title=\"Vitamin Shoppe, Inc.\">VSI</a> <font color=\"green\">+1.6%</font>) merger has been bandied around for quite a while, Morgan Stanley said the <a href=\"http://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Remains+Sidelined+on+GNC+Holdings+%28GNC%29+-+PT+to+%2426/11759641.html\" target=\"_blank\">probability</a> of that outcome was low in a note to investors issued yesterday. </li>   </ul><div class=\"tiny-share-widget\" data-id=\"3190072\" data-linked=\"GNC Holdings and Vitamin Shoppe higher with merger chatter still circulating\" data-tweet=\"$GNC $GNC $VSI - GNC Holdings and Vitamin Shoppe higher with merger chatter still circulating https://seekingalpha.com/news/3190072-gnc-holdings-and-vitamin-shoppe-higher-merger-chatter-still-circulating?source=tweet\" data-url=\"https://seekingalpha.com/news/3190072-gnc-holdings-and-vitamin-shoppe-higher-merger-chatter-still-circulating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190050\" data-ts=\"1466607635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190050-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/NYMX\" title=\"Nymox Pharmaceutical Corporation\">NYMX</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/PSTI\" title=\"Pluristem Therapeutics, Inc.\">PSTI</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/CNXR\" title=\"Connecture\">OTC:CNXR</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/SBOT\" title=\"Stellar Biotechnologies Inc.\">SBOT</a> <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/EBS\" title=\"Emergent BioSolutions Inc.\">EBS</a> <font color=\"red\">-24%</font>. <a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/CBMG\" title=\"Cellular Biomedicine Group, Inc.\">CBMG</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/UAM\" title=\"Universal American Corporation\">UAM</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/MYOS\" title=\"MYOS RENS Technology\">MYOS</a> <font color=\"red\">-7%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190050\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$NYMX $PSTI $CNXR - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3190050-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3190050-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190068\" data-ts=\"1466607297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYMX\" target=\"_blank\">NYMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190068-nymoxs-lead-product-candidate-reduces-incidence-of-prostate-cancer-in-long-term-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nymox&#39;s lead product candidate reduces incidence of prostate cancer in long-term study; shares up 29%</a></h4><ul>\n<li>Thinly traded micro cap Nymox Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/NYMX\" title=\"Nymox Pharmaceutical Corporation\">NYMX</a> <font color=\"green\">+29.2%</font>) heads north on more than a 20x surge in volume in response to its announcement of positive results from its seven-year study of lead drug <a href=\"http://www.nymox.com/default.action?itemid=23\" target=\"_blank\">fexapotide </a>(NX-1207) in men with benign prostate hyperplasia (enlarged prostate) (BPH).</li>\n<li>The study enrolled 995 men across 70 U.S. sites. They were thoroughly evaluated to exclude any prostate cancer prior to treatment in the trial. They were followed for up to seven years (median of five years) after receiving a single transrectal injection of fexapotide.</li>\n<li>The incidence of prostate cancer cases in this group was only 1.3%, much lower than the expected rate of 5 - 20% in the general middle aged/elderly U.S. male population. In a BPH population, major studies have shown the incidence rate to be 20 - 25%.</li>\n<li>The company says the results will support regulatory applications for the BPH indication.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190068\" data-linked=\"Nymox&#39;s lead product candidate reduces incidence of prostate cancer in long-term study; shares up 29%\" data-tweet=\"$NYMX - Nymox&#39;s lead product candidate reduces incidence of prostate cancer in long-term study; shares up 29% https://seekingalpha.com/news/3190068-nymoxs-lead-product-candidate-reduces-incidence-of-prostate-cancer-in-long-term-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3190068-nymoxs-lead-product-candidate-reduces-incidence-of-prostate-cancer-in-long-term-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190051\" data-ts=\"1466603727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HR\" target=\"_blank\">HR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190051-healthcare-realty-and-physicians-realty-lower-after-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Realty and Physicians Realty lower after downgrades</a></h4><ul><li>Healthcare Realty Trust (<a href='https://seekingalpha.com/symbol/HR' title='Healthcare Realty Trust Inc.'>HR</a> <font color='red'>-1.3%</font>) is cut to Underperform from Market Perform, and Physicians Realty Trust (<a href='https://seekingalpha.com/symbol/DOC' title='Physicians Realty Trust'>DOC</a> <font color='red'>-1.5%</font>) to Market Perform from Outperform at JMP Securities.</li><li>The two have moved nearly in lockstep this year, with DOC&nbsp;<font color='green'>up 18.6%</font>&nbsp;and HR&nbsp;<font color='green'>higher by 17.2%</font>. On a year-over-year basis, HR is&nbsp;<font color='green'>ahead 40%</font>&nbsp;and DOC&nbsp;<font color='green'>26%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3190051\" data-linked=\"Healthcare Realty and Physicians Realty lower after downgrades\" data-tweet=\"$HR $HR $DOC - Healthcare Realty and Physicians Realty lower after downgrades https://seekingalpha.com/news/3190051-healthcare-realty-and-physicians-realty-lower-after-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3190051-healthcare-realty-and-physicians-realty-lower-after-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190048\" data-ts=\"1466603049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190048-harley-davidson-lower-after-downgrade-and-discouraging-channel-check\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harley-Davidson lower after downgrade and discouraging channel check</a></h4><ul> <li>Shares of Harley-Davidson (<a href=\"https://seekingalpha.com/symbol/HOG\" title=\"Harley-Davidson, Inc.\">HOG</a> <font color=\"red\">-1.6%</font>) cycle lower after Goldman Sachs <a href=\"http://247wallst.com/investing/2016/06/22/top-analyst-upgrades-and-downgrades-centurylink-gold-fields-papa-johns-priceline-solarcity-tesla-unisys-and-more/\" target=\"_blank\">downgrades</a> the motorcycle stock to Neutral from Buy.</li> <li>ITG is also out with a channel check indicating that Q2 sales are trending below consensus.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3190048\" data-linked=\"Harley-Davidson lower after downgrade and discouraging channel check\" data-tweet=\"$HOG - Harley-Davidson lower after downgrade and discouraging channel check https://seekingalpha.com/news/3190048-harley-davidson-lower-after-downgrade-and-discouraging-channel-check?source=tweet\" data-url=\"https://seekingalpha.com/news/3190048-harley-davidson-lower-after-downgrade-and-discouraging-channel-check\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190042\" data-ts=\"1466601871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190042-premarket-gainers-losers-of-9-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:15 am</a></h4><ul> <li><b>Gainers:</b> SPU <font color='green'>+90%</font>. <a href='https://seekingalpha.com/symbol/INVT' title='Inventergy Global, Inc.'>OTC:INVT</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='green'>+17%</font>. SCTY <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ECTE' title='Echo Therapeutics'>OTC:ECTE</a> <font color='green'>+8%</font>. PBMD <font color='green'>+7%</font>. EBIO <font color='green'>+7%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/QEP' title='QEP Resources, Inc.'>QEP</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3190042\" data-linked=\"Premarket Gainers / Losers as of 9:15 am\" data-tweet=\"$FTFT $INVT $SUNW - Premarket Gainers / Losers as of 9:15 am https://seekingalpha.com/news/3190042-premarket-gainers-losers-of-9-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3190042-premarket-gainers-losers-of-9-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190035\" data-ts=\"1466601126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVT\" target=\"_blank\">INVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190035-inventergyplus-65-after-winning-23-new-telecom-mobile-broadband-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inventergy +65% after winning 23 new telecom, mobile broadband patents</a></h4><ul>     <li>Inventergy (<a href=\"https://seekingalpha.com/symbol/INVT\" title=\"Inventergy Global, Inc.\">OTC:INVT</a>) <font color=\"green\">+65.2%</font> premarket after the company announces it will be granted 23 new patents in telecommunications and mobile broadband.</li>\n<li>INVT says the previously pending patent applications include 15 patents in five   families of the IMS/VoIP portfolios  originally purchased from Nokia and  Huawei, and eight patents in three families  included in the Mobile  Broadband portfolio originally purchased from Panasonic.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190035\" data-linked=\"Inventergy +65% after winning 23 new telecom, mobile broadband patents\" data-tweet=\"$INVT - Inventergy +65% after winning 23 new telecom, mobile broadband patents https://seekingalpha.com/news/3190035-inventergyplus-65-after-winning-23-new-telecom-mobile-broadband-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3190035-inventergyplus-65-after-winning-23-new-telecom-mobile-broadband-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190040\" data-ts=\"1466600706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNW\" target=\"_blank\">SUNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190040-sunworksplus-18-after-winning-24m-in-new-commercial-orders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunworks +18% after winning $24M in new commercial orders</a></h4><ul>\n<li>Sunworks (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SUNW\" title=\"Sunworks, Inc.\">SUNW</a>) <font color=\"green\">+18%</font> premarket on news that it has been  awarded ~$24M in new commercial solar solution  orders totaling more than 12 MW since it released its Q1 earnings.</li>\n<li>SUNW says the orders increased itss  backlog to a record high exceeding $50M at the end of May with  strong additional sales in June.</li>\n<li>SUNW now projects $100M in  revenue for FY 2016.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190040\" data-linked=\"Sunworks +18% after winning $24M in new commercial orders\" data-tweet=\"$SUNW - Sunworks +18% after winning $24M in new commercial orders https://seekingalpha.com/news/3190040-sunworksplus-18-after-winning-24m-in-new-commercial-orders?source=tweet\" data-url=\"https://seekingalpha.com/news/3190040-sunworksplus-18-after-winning-24m-in-new-commercial-orders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190026\" data-ts=\"1466600084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190026-ocwen-surges-premarket-on-good-news-from-fitch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocwen surges premarket on good news from Fitch</a></h4><ul>\n<li>\n<a href=\"http://www.kctv5.com/story/32275008/fitch-affirms-ocwen-financial-corp-at-b-outlook-stable\" target=\"_blank\">Fitch affirms</a> Ocwen Financial's (NYSE:<a href=\"https://seekingalpha.com/symbol/OCN\" title=\"Ocwen Financial Corporation\">OCN</a>) long-term issuer default ratings and the rating on the company's senior secured term loan (SSTL). The outlook is stable.</li>\n<li>As for whether New Residential (NYSE:<a href=\"https://seekingalpha.com/symbol/NRZ\" title=\"New Residential Investment Corp.\">NRZ</a>) might exercise its right to transfer non-agency servicing rights away from Ocwen, Fitch acknowledges the risk, but says such a move is unlikely given the required third-party consents and licenses, not to mention Ocwen's skill at servicing these mortgages at such low cost.</li>\n<li>Ocwen is <font color=\"green\">higher by 11%</font> in modest premarket trading. Altisource Portfolio Solutions (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ASPS\" title=\"Altisource Portfolio Solutions SA\">ASPS</a>) is <font color=\"green\">up 1.9% </font>in very thin action.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190026\" data-linked=\"Ocwen surges premarket on good news from Fitch\" data-tweet=\"$OCN $OCN $NRZ - Ocwen surges premarket on good news from Fitch https://seekingalpha.com/news/3190026-ocwen-surges-premarket-on-good-news-from-fitch?source=tweet\" data-url=\"https://seekingalpha.com/news/3190026-ocwen-surges-premarket-on-good-news-from-fitch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190019\" data-ts=\"1466599241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190019-priceline-perks-up-after-barclays-points-to-margin-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Priceline perks up after Barclays points to margin potential</a></h4><ul> <li>Shares of Priceline (PCLN) are on watch after a timely upgrade from Barclays arrives.</li> <li>The investment firm moves to an Overweight rating from Equal Weight on its view profit margins will expand.</li> <li>\"PCLN still stands out to us as an inexpensive name relative to structural trends and expected growth. We believe there is a valuation disconnect from concerns that are either timing-related or mostly played out,\" reads the note from analyst Christopher Merwin.</li> <li>PCLN <font color=\"green\">+2.01%</font> premarket to $1370.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190019\" data-linked=\"Priceline perks up after Barclays points to margin potential\" data-tweet=\"$BKNG - Priceline perks up after Barclays points to margin potential https://seekingalpha.com/news/3190019-priceline-perks-up-after-barclays-points-to-margin-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3190019-priceline-perks-up-after-barclays-points-to-margin-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190015\" data-ts=\"1466598228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190015-hard-sell-from-musk-on-tesla-motors-solarcity-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hard sell from Musk on Tesla Motors-SolarCity deal</a></h4><ul> <li>Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) CEO Elon Musk is holding a <a href=\"http://ir.tesla.com/events.cfm\" target=\"_blank\">a second conference call</a> this morning to add more details on the SolarCity (SCTY) deal.</li> <li>Musk begins by explaining how a consumer with a PowerWall, solar panels, and car-charging infrastructure will be able to do a single install after making a bundled purchase.</li> <li>\"If we didn\u2019t do this, it would make Tesla\u2019s execution harder and worse,\" he adds.</li> <li>There isn't a great amount of granular detail on Tesla's debt load. \"Cash flow covers what\u2019s required with the recourse debt,\" he maintains.</li> <li>As the Q&amp;A goes on, Musk's insistence that the deal must happen if Tesla and SolarCity are to scale up adds intrigue to what would happen if either board voted down the combination. Just last night, Credit Suisse forecast only a 20% to 40% chance of the deal closing.</li> <li>On Wall Street, perma-bulls like Global Equities are <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/06/8137837/teslas-acquisition-of-solar-city-would-be-groundbreaking\" target=\"_blank\">backing the deal</a> wholeheartedly, while Oppenheimer has <a href=\"http://www.marketbeat.com/stocks/NASDAQ/TSLA/\" target=\"_blank\">downgraded</a> Tesla to Market Perform from Outperform. Baird is playing it down the <a href=\"http://www.streetinsider.com/Analyst+Comments/Tesla+Motors+%28TSLA%29+Could+See+Near-Term+Pressure+Amid+SolarCity+%28SCTY%29+Bid%3B+Long-Term+Looks+Good+-+Baird/11762480.html\" target=\"_blank\">middle</a> by calling out near-term risks for shares, but staying bullish on the long-term Tesla story.</li> <li>TSLA <font color=\"red\">-11.06%</font> premarket to $195.32, nearly unchanged during the conference call. SCTY <font color=\"green\">+14.77%</font> to $24.32.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3189956-tesla-proposes-buy-solar-city-26_50-28_50-share\" target=\"_blank\">Tesla proposes to buy Solar City for $26.50-$28.50/share</a> (June 21)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3189965-tesla-offer-solarcity-distracting-defies-common-sense\" target=\"_blank\">Tesla offer for SolarCity \"distracting,\" \"defies common sense\"</a> (June 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190015\" data-linked=\"Hard sell from Musk on Tesla Motors-SolarCity deal\" data-tweet=\"$TSLA - Hard sell from Musk on Tesla Motors-SolarCity deal https://seekingalpha.com/news/3190015-hard-sell-from-musk-on-tesla-motors-solarcity-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3190015-hard-sell-from-musk-on-tesla-motors-solarcity-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190012\" data-ts=\"1466598070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTK\" target=\"_blank\">PRTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190012-paratek-prices-equity-offering-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paratek prices equity offering; shares up 2% premarket</a></h4><ul><li>Thinly traded micro cap Paratek Pharmaceutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PRTK\" title=\"Paratek Pharmaceuticals, Inc.\">PRTK</a>) inches up <font color=\"green\">2%</font> premarket on increased volume after the company announced that it has priced its public offering of 4.25M shares of common stock at $13 a share. Underwriters over-allotment is an additional 637.5K shares. Net proceeds should be ~$51.4M. Closing date is June 27.</li></ul><div class=\"tiny-share-widget\" data-id=\"3190012\" data-linked=\"Paratek prices equity offering; shares up 2% premarket\" data-tweet=\"$PRTK - Paratek prices equity offering; shares up 2% premarket https://seekingalpha.com/news/3190012-paratek-prices-equity-offering-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3190012-paratek-prices-equity-offering-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190003\" data-ts=\"1466595775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLBH\" target=\"_blank\">CLBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190003-first-bancorp-to-buy-carolina-bank-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Bancorp to buy Carolina Bank Holdings</a></h4><ul>\n<li>The cash and stock deal has a total current value of $97.3M or $19.26 per share. Carolina Bank (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLBH\" title=\"Carolina Bank Holdings Inc.\">CLBH</a>) owners will receive either 1.0002 shares of First Bancorp (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FBNC\" title=\"First Bancorp\">FBNC</a>) or $20 in cash for each share of CLBH they hold, subject to total consideration being 75% stock/25% cash.</li>\n<li>CLBH closed at $15.98 last night.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3190003\" data-linked=\"First Bancorp to buy Carolina Bank Holdings\" data-tweet=\"$CLBH $CLBH $FBNC - First Bancorp to buy Carolina Bank Holdings https://seekingalpha.com/news/3190003-first-bancorp-to-buy-carolina-bank-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3190003-first-bancorp-to-buy-carolina-bank-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3190002\" data-ts=\"1466595451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WGO\" target=\"_blank\">WGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3190002-winnebago-positive-post-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Winnebago positive post earnings beat</a></h4><ul>     <li>Winnebago (NYSE:<a href=\"https://seekingalpha.com/symbol/WGO\" title=\"Winnebago Industries, Inc.\">WGO</a>) reports revenue rose 2.1% in <a href=\"http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzQyNTY2fENoaWxkSUQ9LTF8VHlwZT0z&amp;t=1&amp;cb=636021777402268134\" target=\"_blank\">F</a><a href=\"http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzQyNTY2fENoaWxkSUQ9LTF8VHlwZT0z&amp;t=1&amp;cb=636021777402268134\" target=\"_blank\">Q3</a> primarily due to higher shipments of 12.4% in motorized units and 62.4% in towables.</li>     <li>Gross margin improved 50 bps to 11.1% primarily due to strategic sourcing initiative resulting in lower raw material costs and favorable product mix.</li>     <li>Operating margin rate increased 160 bps to 7.6%.</li>     <li>Total motor homes deliveries +12.4% Y/Y to 2,917.</li>     <li>Total towables deliveries +62.4% Y/Y to 1,205.</li>     <li>Dealer inventory: Motor homes +1.9% to 4,585; towables +29.3% to 2,358.</li>     <li>WGO <font color=\"green\">+6.43%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3190002\" data-linked=\"Winnebago positive post earnings beat\" data-tweet=\"$WGO - Winnebago positive post earnings beat https://seekingalpha.com/news/3190002-winnebago-positive-post-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3190002-winnebago-positive-post-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3189999\" data-ts=\"1466594493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3189999-pluristems-plx-pad-cells-shows-positive-effect-in-animal-model-of-muscular-dystrophy-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem&#39;s PLX-PAD cells shows positive effect in animal model of muscular dystrophy; shares up 11% premarket</a></h4><ul>\n<li>Thinly traded nano cap Pluristem Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PSTI\" title=\"Pluristem Therapeutics, Inc.\">PSTI</a>) is up <font color=\"green\">11%</font> premarket on light volume in response to its announcement of preclinical data that suggest its PLX-PAD cells may be effective in treating Duchenne muscular dystrophy.</li>\n<li>In a mouse model study, PLX-PAD cells reduced an enzyme called creatine phosphokinase (CPK), a marker of muscle degeneration or injury, by ~50% compared to placebo. In addition, analyses of tissue samples showed reduced levels of inflammation and <a href=\"https://en.wikipedia.org/wiki/Necrosis\" target=\"_blank\">necrosis</a> (death of most of the cells in an organ or tissue) and evidence of regeneration of muscle tissue.</li>\n<li>PLX cells are mesenchymal-like adherent stromal cells derived from full term human placentas that may be administered without the need for HLA matching. According to the company, <a href=\"http://www.pluristem.com/mechanism-of-action/\" target=\"_blank\">PLX-PAD</a> (peripheral artery disease) cells have demonstrated the ability to stimulate the growth of new blood vessels in preclinical models inducing muscle tissue regeneration and improving muscle function.</li>\n<li>PLX-PAD is currently under development for the treatment of critical limb ischemia, intermittent <a href=\"http://www.mayoclinic.org/diseases-conditions/claudication/basics/definition/con-20033581\" target=\"_blank\">claudication </a>(leg cramps caused by the obstruction of arteries), muscle injury, pulmonary arterial hypertension and preeclampsia.</li>\n<li>DMD-related tickers: (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>)(NASDAQ:<a href=\"https://seekingalpha.com/symbol/BMRN\" title=\"BioMarin Pharmaceutical Inc.\">BMRN</a>)(NASDAQ:<a href=\"https://seekingalpha.com/symbol/SMMT\" title=\"Summit Therapeutics\">SMMT</a>)(NASDAQ:<a href=\"https://seekingalpha.com/symbol/PTCT\" title=\"PTC Therapeutics\">PTCT</a>)(NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>)(NASDAQ:<a href=\"https://seekingalpha.com/symbol/MRNA\" title=\"Moderna, Inc.\">MRNA</a>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3189999\" data-linked=\"Pluristem&#39;s PLX-PAD cells shows positive effect in animal model of muscular dystrophy; shares up 11% premarket\" data-tweet=\"$PSTI $PSTI $SRPT - Pluristem&#39;s PLX-PAD cells shows positive effect in animal model of muscular dystrophy; shares up 11% premarket https://seekingalpha.com/news/3189999-pluristems-plx-pad-cells-shows-positive-effect-in-animal-model-of-muscular-dystrophy-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3189999-pluristems-plx-pad-cells-shows-positive-effect-in-animal-model-of-muscular-dystrophy-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":37,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}